NIFTY 50 22795.9 ▼ (0.51%)
NIFTY NEXT 50 60466.8 ▼ (0.94%)
NIFTY 100 23274.05 ▼ (0.59%)
NIFTY MIDCAP 100 50486.2 ▼ (1.32%)
NIFTY SMALLCAP 100 15636.9 ▼ (0.7%)
NIFTY SMALLCAP 250 14683.4 ▼ (0.57%)
NIFTY MIDCAP SELECT 11198.9 ▼ (1.69%)
NIFTY TOTAL MARKET 11634.25 ▼ (0.67%)
NIFTY BANK 48981.2 ▼ (0.72%)
SENSEX 75311.06 ▼ (0.56%)
BSE BANKEX 55718.18 ▼ (0.82%)

Vijaya Diagnostic Centre ‘s Q3 2024-25 Latest News: Revenue Rises by 21.02% YoY

[fetch_key]

Highlights

🔹 The presented financial data is Standalone to provide a comprehensive overview of the company performance.
🔹 Sales over the Year and quarter: The company experienced a substantial growth of 21.02 % in the past year, decrease in net sales/revenue by -7.33 %.
🔹 Income over the Year and quarter: There has been either a marginal increase or a decline in other income over the past year which is 55.77 %. Marginal increase in other income during this quarter, up by 3.89%.
🔹 Profit over the Year and quarter: Significant improvement in profitability for Vijaya Diagnostic Centre Limited. Notable increase of 32.83 % in net profit Year to Year, Vijaya Diagnostic Centre Limited’s profitability dropped by -15.1 % Quarter to Quarter.
🔹 EPS over the Year and quarter: EPS increased by 31.98 % Year to Year. EPS decreased by -15.32 % in previous quarter. Analysis needed for shareholder value.

This report meticulously dissects the performance of Vijaya Diagnostic Centre Limited, offering a panoramic view of its operational success and challenges. It delves into a variety of financial metrics, such as revenue growth, profit margins, and shareholder returns, juxtaposed against the backdrop of broader economic conditions and sector-specific trends. The analysis further explores the investor community’s perception and expectations, which influence the stock’s volatility and potential returns. By providing a forecast based on quantitative analyses and market sentiment, the report aims to outline the potential risks and rewards, guiding investors toward making strategic, data-driven investment choices.

Metrics Previous Year Previous Quarter Current Quarter Quarter to Quarter Difference Year to Year Difference
Sales Rs. 129.118 Cr Rs. 168.607 Cr Rs. 156.255 Cr -7.33 % + 21.02 %
Expenses Rs. 78.03 Cr Rs. 98.45 Cr Rs. 93.78 Cr -4.74 % + 20.18 %
Operating Profit Rs. 51.09 Cr Rs. 70.16 Cr Rs. 62.48 Cr -10.95 % + 22.29 %
OPM % 39.57 % 41.61 % 39.99 % -1.62 % + 0.42 %
Other Income Rs. 3.204 Cr Rs. 4.804 Cr Rs. 4.991 Cr + 3.89 % + 55.77 %
Interest Rs. 6.05 Cr Rs. 6.07 Cr Rs. 6.26 Cr + 3.13 % + 3.47 %
Depreciation Rs. 14.4 Cr Rs. 15.37 Cr Rs. 16.86 Cr + 9.69 % + 17.08 %
Profit before tax Rs. 33.84 Cr Rs. 53.52 Cr Rs. 44.35 Cr -17.13 % + 31.06 %
Tax % 25.39 % 26.21 % 24.39 % -1.82 % -1 %
Net Profit Rs. 25.25 Cr Rs. 39.5 Cr Rs. 33.53 Cr -15.11 % + 32.79 %
EPS in Rs Rs. 2.46 Rs. 3.84 Rs. 3.26 -15.1 % + 32.52 %


Today, we’re looking at Vijaya Diagnostic Centre Limited’s financial performance for the Q3(Dec 2024-25).Starting with the top line, the company reported a robust year-over-year sales growth of 21.02 %. However, it did see a marginal slip of -7.33 % from the previous quarter. Expenses decreased slightly by -4.74 % quarter-on-quarter, aligning with the annual rise of 20.18 %. Operating profit, while up 22.29 % compared to last year, faced a quarter-on-quarter dip of -10.95 %, signaling a short-term contraction in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 0.42 %, but a shrinkage of -1.62 % sequentially. Other income rose by 3.89 % compared to the last quarter, despite an annual growth of 55.77 %. Interest expenses surged remarkably by 3.13 % from the previous quarter, yet the year-over-year increase remains at a moderate 3.47 %. Depreciation costs climbed by 9.69 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 17.08 %. Profit before tax grew annually by 31.06 % but saw a reduction from the preceding quarter by -17.13 %.
Tax expenses as a percentage of profits decreased slightly by -1 % compared to last year, with a more notable quarter-on-quarter decrease of -1.82 %. Net profit rose by 32.79 % year-on-year but witnessed a -15.11 % contraction from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 32.52 % but a quarterly fall of -15.1 %. In summary, Vijaya Diagnostic Centre Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.

Metrics Previous Year Previous Quarter Current Quarter Quarter to Quarter Difference Year to Year Difference
Sales Rs. 129.118 Cr Rs. 168.607 Cr Rs. 156.255 Cr -7.33 % + 21.02 %
Expenses Rs. 78.03 Cr Rs. 98.45 Cr Rs. 93.78 Cr -4.74 % + 20.18 %
Operating Profit Rs. 51.09 Cr Rs. 70.16 Cr Rs. 62.48 Cr -10.95 % + 22.29 %
Net Profit Rs. 25.25 Cr Rs. 39.5 Cr Rs. 33.53 Cr -15.11 % + 32.79 %
EPS in Rs Rs. 2.46 Rs. 3.84 Rs. 3.26 -15.1 % + 32.52 %


In reviewing Vijaya Diagnostic Centre Limited’s 2024-25(Q3) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 21.02 % year-on-year growth, although there was a slight dip of -7.33 % from the previous quarter. Expenses rose by 20.18 % compared to the previous year, with a decrease of -4.74 % quarter-on-quarter. Operating Profit surged by 22.29 % annually, and saw a -10.95 % decrease from the last quarter.
Net Profit showed yearly increase of 32.79 %, and experienced a -15.11 % decrease from the previous quarter. Earnings Per Share (EPS) rose by 32.52 % annually, however dipped by -15.1 % compared to the last quarter. In essence, while Vijaya Diagnostic Centre Limited exhibits strong annual growth indicators, short-term fluctuations suggest the need for agile strategies to navigate market dynamics effectively. That’s all for now in the financial sector.

Join our telegram for more updates

Stay Updated with Our YouTube Videos

Related Post